Addus HomeCare (NASDAQ:ADUS) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Key Points

• Addus HomeCare reported $1.31 earnings per share for the quarter, missing analyst expectations by $0.14.
• The stock's current market capitalization stands at $1.97 billion, with shares trading around $106.96.
• Research analysts have a consensus target price of $142.57 for Addus HomeCare, with several recently reaffirming a "buy" rating on the stock.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) posted its earnings results on Monday. The company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.04, Briefing.com reports. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. During the same quarter in the prior year, the business earned $1.35 EPS. The business's revenue for the quarter was up 21.8% compared to the same quarter last year.

Addus HomeCare Price Performance

Shares of ADUS stock traded up $0.05 on Friday, reaching $109.15. The company's stock had a trading volume of 33,242 shares, compared to its average volume of 192,875. The stock's fifty day simple moving average is $111.77 and its 200-day simple moving average is $108.20. Addus HomeCare has a 1 year low of $88.96 and a 1 year high of $136.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of 23.99, a price-to-earnings-growth ratio of 1.72 and a beta of 0.80.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently made changes to their positions in the company. Royal Bank of Canada lifted its holdings in shares of Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock worth $682,000 after purchasing an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock worth $1,026,000 after purchasing an additional 459 shares during the period. Jane Street Group LLC lifted its holdings in shares of Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Intech Investment Management LLC lifted its holdings in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock worth $1,420,000 after purchasing an additional 4,439 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock worth $5,111,000 after purchasing an additional 2,952 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Analyst Ratings Changes

ADUS has been the subject of several analyst reports. TD Cowen increased their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday. Macquarie reissued an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Seven analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $142.86.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.